Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)

Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh, Ruta Rao, Steven B. Feinstein, Lydia Usha, Kathrin Banach, Jochen Reiser, Tochukwu M. Okwuosa

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Correction to: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin-treated breast cancer patients: a prospective exploratory study (Cardio-Oncology, (2024), 10, 1, (3), 10.1186/s40959-023-00191-0)'. Together they form a unique fingerprint.

Medicine & Life Sciences